Weiss Multi Strategy Advisers LLC Fate Therapeutics Inc Transaction History

Weiss Multi Strategy Advisers LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $262,015 - $532,332	-8,831 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $1,817 - $2,444	-38 Reduced 0.43%	8,831 $517,000
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $126,304 - $204,000	-2,131 Reduced 19.37%	8,869 $526,000
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $69,133 - $95,110	-1,028 Reduced 8.55%	11,000 $955,000
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $214,459 - $348,912	-2,972 Reduced 19.81%	12,028 $992,000
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $198,982 - $527,362	-5,224 Reduced 25.83%	15,000 $1.36 Million
Q3 2020 Nov 16, 2020	BUY	$30.41 - $40.5 $6,811 - $9,072	224 Added 1.12%	20,224 $808,000
Q2 2020 Aug 14, 2020	BUY	$20.21 - $35.23 $209,577 - $365,335	10,370 Added 107.68%	20,000 $686,000
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $6,393 - $11,795	-370 Reduced 3.7%	9,630 $214,000
Q4 2019 Feb 14, 2020	SELL	$13.39 - $20.73 $133,900 - $207,300	-10,000 Reduced 50.0%	10,000 $196,000
Q2 2019 Aug 14, 2019	SELL	$15.61 - $20.44 $54,635 - $71,540	-3,500 Reduced 14.89%	20,000 $406,000
Q1 2019 May 15, 2019	BUY	$13.15 - $18.71 $3,668 - $5,220	279 Added 1.2%	23,500 $413,000
Q4 2018 Feb 14, 2019	SELL	$11.48 - $16.98 $77,822 - $115,107	-6,779 Reduced 22.6%	23,221 $298,000
Q3 2018 Nov 14, 2018	BUY	$8.75 - $16.29 $262,500 - $488,700	30,000 New	30,000 $489,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.